CavaGene Story: CavaGene was founded to transform cancer diagnostics and treatment by integrating advanced AI and genomic technologies in global health communities. Our journey started when the founder, leveraging his extensive expertise in pharmaceuticals and computer science, identified the urgent need for early, accurate cancer diagnosis to access care in public health communities. Recognizing the potential of evidence-based generative AI and genomics, we envision a future where non-invasive methods could transform cancer care to equal treatment access globally.
Mission for the World: At CavaGene, we are dedicated to Transforming Cancer Care by making early detection and personalized treatment universally accessible. Using secure, saliva-based genomic data, we create seamless, noninvasive diagnostics, starting with breast cancer and expanding to other cancers to improve patient outcomes and quality of life. Our mission supports global public health by addressing social determinants, health equity, and information disparities.
Cutting-Edge AI Technology: With cutting-edge AI, including Retrieval-Augmented Generation (RAG) in Natural Language Processing (NLP) and Large Multimodal Model (LMM)-based agents with agentic orchestration layer of LangChain, we enhance access to accurate health data, empowering underserved communities worldwide.
Touvron, Hugo, et al. "LLaMA: Open and Efficient Foundation Language Models." arXiv preprint arXiv:2302.13971 (2023)
Driess, Danny, et al. "PaLM-E: An Embodied Multimodal Language Model." arXiv preprint arXiv:2303.03378 (2023)
Yang, Ziwei, et al. "Cancer Subtyping via Embedded Unsupervised Learning on Transcriptomics Data." arXiv preprint arXiv:2204.09498 (2022)
Wang, Xi, et al. "Benchmarking Algorithms for Gene Set Scoring of Single-cell ATAC-seq Data." Genomics, Proteomics & Bioinformatics 22.2 (2024)
Testimonials
Anna K, Breast Cancer Patient
“Receiving a breast cancer diagnosis was stressful, especially with the thought of invasive biopsies. CavaGene’s saliva-based test process was simple and non-invasive, which reduced my anxiety significantly. Thanks to early detection through their technology. I’m now on the path to recovery and grateful for the innovative approach that CavaGene offers.”
Dr. Johnson, Oncologist
“CavaGene’s approach to cancer diagnostics has transformed how we screen and treat patients. The ability to use saliva samples for genomic testing is not only less stressful for patients but also yields highly reliable data. This innovation has allowed us to personalize treatment plans more effectively, improving patient outcomes significantly.”
Dr. Davis, CEO of Wellness Clinic
“Partnering with CavaGene has enhanced our diagnostic capabilities immensely. Their cutting-edge technology aligns perfectly with our mission to provide comprehensive, patient-centered care. The feedback from our patients has been overwhelmingly positive, and we’ve seen significant improvements in early detection rates.”
CavaGene 